Sers C - Search Results

1

The class II tumour suppressor gene H-REV107-1 is a target of interferon-regulatory factor-1 and is involved in IFNgamma-induced cell death in human ovarian carcinoma cells.

Sers C, Husmann K, Nazarenko I, Reich S, Wiechen K, Zhumabayeva B, Adhikari P, Schröder K, Gontarewicz A, Schäfer R. Sers C, et al. Oncogene. 2002 Apr 25;21(18):2829-39. doi: 10.1038/sj.onc.1205377. Oncogene. 2002. PMID: 11973642

2

Negative Hyperselection of Resistance Mutations for Panitumumab Maintenance in RAS Wild-Type Metastatic Colorectal Cancer (PanaMa Phase II Trial, AIO KRK 0212).

Stahler A, Kind AJ, Sers C, Mamlouk S, Müller L, Karthaus M, Fruehauf S, Graeven U, Fischer von Weikersthal L, Sommerhäuser G, Kasper S, Hoppe B, Kurreck A, Held S, Heinemann V, Horst D, Jarosch A, Stintzing S, Trarbach T, Modest DP. Stahler A, et al. Among authors: sers c. Clin Cancer Res. 2024 Apr 1;30(7):1256-1263. doi: 10.1158/1078-0432.CCR-23-3023. Clin Cancer Res. 2024. PMID: 38289994 Clinical Trial.

3

BannMI deciphers potential n-to-1 information transduction in signaling pathways to unravel message of intrinsic apoptosis.

Schmidt B, Sers C, Klein N. Schmidt B, et al. Among authors: sers c. Bioinform Adv. 2023 Nov 29;4(1):vbad175. doi: 10.1093/bioadv/vbad175. eCollection 2024. Bioinform Adv. 2023. PMID: 38187472 Free PMC article.

4

Transcriptomic Deconvolution of Neuroendocrine Neoplasms Predicts Clinically Relevant Characteristics.

Otto R, Detjen KM, Riemer P, Fattohi M, Grötzinger C, Rindi G, Wiedenmann B, Sers C, Leser U. Otto R, et al. Among authors: sers c. Cancers (Basel). 2023 Feb 1;15(3):936. doi: 10.3390/cancers15030936. Cancers (Basel). 2023. PMID: 36765893 Free PMC article.

5

Growth-inhibitory activity and downregulation of the class II tumor-suppressor gene H-rev107 in tumor cell lines and experimental tumors.

Sers C, Emmenegger U, Husmann K, Bucher K, Andres AC, Schäfer R. Sers C, et al. J Cell Biol. 1997 Feb 24;136(4):935-44. doi: 10.1083/jcb.136.4.935. J Cell Biol. 1997. PMID: 9049257 Free PMC article.

6

Transcriptional and translational downregulation of H-REV107, a class II tumour suppressor gene located on human chromosome 11q11-12.

Husmann K, Sers C, Fietze E, Mincheva A, Lichter P, Schäfer R. Husmann K, et al. Among authors: sers c. Oncogene. 1998 Sep 10;17(10):1305-12. doi: 10.1038/sj.onc.1202060. Oncogene. 1998. PMID: 9771974

7

Gene expression profiling of fibroblasts resistant toward oncogene-mediated transformation reveals preferential transcription of negative growth regulators.

Tchernitsa OI, Zuber J, Sers C, Brinckmann R, Britsch SK, Adams V, Schäfer R. Tchernitsa OI, et al. Among authors: sers c. Oncogene. 1999 Sep 23;18(39):5448-54. doi: 10.1038/sj.onc.1202987. Oncogene. 1999. PMID: 10498898

8

A genome-wide survey of RAS transformation targets.

Zuber J, Tchernitsa OI, Hinzmann B, Schmitz AC, Grips M, Hellriegel M, Sers C, Rosenthal A, Schäfer R. Zuber J, et al. Among authors: sers c. Nat Genet. 2000 Feb;24(2):144-52. doi: 10.1038/72799. Nat Genet. 2000. PMID: 10655059

9

Oncogenic transformation increases the sensitivity for apoptosis induction by inhibitors of macromolecular synthesis.

Hanusch J, Schwieger A, Sers C, Schäfer R, Bauer G. Hanusch J, et al. Among authors: sers c. Int J Oncol. 2000 Jul;17(1):89-95. Int J Oncol. 2000. PMID: 10853023

10

Down-regulation of caveolin-1, a candidate tumor suppressor gene, in sarcomas.

Wiechen K, Sers C, Agoulnik A, Arlt K, Dietel M, Schlag PM, Schneider U. Wiechen K, et al. Among authors: sers c. Am J Pathol. 2001 Mar;158(3):833-9. doi: 10.1016/S0002-9440(10)64031-X. Am J Pathol. 2001. PMID: 11238032 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

125 results

Search Page